LIM domain only 2 (LMO2) expression distinguishes T-lymphoblastic leukemia/lymphoma from indolent T-lymphoblastic proliferations.
Nivaz BrarAlexandra ButzmannJyoti KumarRaheem PeeraniElizabeth A MorganGeorge GrigoriadisBeena KumarR Maciej TatarczuchRoger A WarnkeRobert S OhgamiPublished in: Histopathology (2020)
We confirm previously published findings that iT-LBP cases show highly overlapping morphological and immunophenotypic features with T-LBL. Importantly, LMO2 expression is a sensitive and specific marker with which to rule out iT-LBP.